| Class | CCY | SZE(M) | WAL | MO | SP | FI | DR | KR | C/E | LTV | TYPE | BNCH | GDNC | SPRD | CPN | YLD | PRICE |
|---|
| A1R-R | USD | 310.000 | - | Aaa | - | - | - | - | - | - | Floating | 3mL | - | 108 | 3mL+108 | - | - |
| A2R-R | USD | 64.700 | - | Aa2 | - | - | - | - | - | - | Floating | 3mL | - | 165 | 3mL+165 | - | - |
| BR-R | USD | 23.000 | - | A2 | - | - | - | - | - | - | Floating | 3mL | - | 230 | 3mL+230 | - | - |
| CR-R | USD | 30.200 | - | Baa3 | - | - | - | - | - | - | Floating | 3mL | - | 350 | 3mL+350 | - | - |
Tranche Comments
A1R-R: First Pay: 2021-10-20; Redemption: 2022-09-29;
A2R-R: First Pay: 2021-10-20; Redemption: 2022-09-29;
BR-R: First Pay: 2021-10-20; Redemption: 2022-09-29;
CR-R: First Pay: 2021-10-20; Redemption: 2022-09-29;
Deal Comments
Refinancing.Non Call Period: 1.00
Reinvestment Period (YRS)
3
Reinvestment Period End Date
Jan 20, 2024
| Sector | Name | Type | Publisher | Date |
|---|
CLOS | Carlyle Global Market Strategies Euro CLO 2015-2 | Performance Analytics | Dealscribe | Mar 4, 2022
|